CBIIF News and Press, Skylight Health Group From 06/19/20

CB2 Insights ( OTCQB:CBIIF ): FY GAAP EPS of -$0.14. More news on: CB2 Insights Inc., Earnings news and commentary, , Read more ...

TORONTO, June 18, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE: CBII; OTCQB: CBIIF) (“CB2” or the “Company”), one of the largest integrative healthcare system in the United States, today reported its audited consolidated financial results for the year ended Decembe...

TORONTO, June 18, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE: CBII; OTCQB: CBIIF) (“CB2” or the “Company”), announces that it has amended the terms of its issued and outstanding promissory note held by Merida Capital Partners (“Merida”), which is de...

TORONTO, June 15, 2020 (GLOBE NEWSWIRE) -- CB2 Insights Inc. (“ CB2 ” or the “ Company ”) (CSE: CBII; OTCQB: CBIIF) announces that it has been delayed in filing its annual financial statements (the “ Annual Financial Statements ”) and associated m...

TORONTO, June 10, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“ CB2 ” or the “ Company ”), announces an update further to its news release of April 20, 2020, with respect to: (i) the filing its audited annual financial statements for the year ...

TORONTO, May 07, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), has announced that it has achieved its target of reaching profitability. On an unaudited basis, the Company has seen positive EBITDA for April 2020. Amidst t...

TORONTO, April 29, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), has announced that it has officially launched its newest division Skylight Health Group (“SHG”) as part of its clinical operations in the Uni...

TORONTO, April 20, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), has announced that it has completed the terms of the purchase agreement of Colorado-based Rae of Sunshine Health Services (“ROSH”; “Re...

TORONTO, April 15, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), has announced that due to circumstances created by the COVID – 19 pandemic it will not be filing its Financial Statements for the Fiscal Year ended ...

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, has launched the med...